ClinConnect ClinConnect Logo
Search / Trial NCT06884696

Study of Placental Inflammation in Gestational Diabetes

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 18, 2025

Trial Information

Current as of April 23, 2025

Active, not recruiting

Keywords

ClinConnect Summary

The aim of this study is to investigate systemic and placental inflammation in women with gestational diabetes mellitus, in particular the role of inflammasome NLRP3 and the chemokine scavenger decoy receptor D6, compared to women with uncomplicated pregnancy

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with gestational diabetes mellitus
  • Women with uncomplicated pregnancy
  • Age \>18 years
  • Singleton pregnancy
  • Exclusion Criteria:
  • Age \< 18 years
  • Infections (HIV,HCV)
  • Multiple pregnancy
  • Cancer

Trial Officials

Chiara Tersigni

Principal Investigator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

About Fondazione Policlinico Universitario Agostino Gemelli Irccs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.

Locations

Rome, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported